D Spectrum - Diabetes - Am Diabetes Assoc The purpose of this study was to evaluate the Safety and efficacy of the orally
administered protein kinase C (PKC) β isoform-selective inhibitor ruboxistaurin
(RBX) in subjects with moderately severe to very severe nonproliferative ... Related articles - All 4 versions
MC Ruddy, WJ Mroczek - Pharmacotherapy - ncbi.nlm.nih.gov STUDY OBJECTIVE. To compare the clinical safety and efficacy of ramipril, a new
long-acting nonsulfhydryl inhibitor of angiotensin-converting enzyme (ACE), with
enalapril. DESIGN. A randomized, double-blind trial. SETTING. Multicenter ... Cited by 5 - Related articles - BL Direct - All 2 versions
V Pezzino, V Papa, A Costantino, L Frittitta, P … - Journal of Clinical Endocrinology & Metabolism, 1992 - Endocrine Soc 0021-972x/92/7405-1116$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright Q 1992 by The Endocrine Society ... LUCIA FRITTITTA, PIETRO RUSSO,
IRA D. GOLDFINE, AND RICCARDO VIGNERI ... Cattedra di Scienza delle ... Cited by 7 - Related articles - All 3 versions
[CITATION] A projection model of the prevalence of selected chronic diseases in the inmate population
EM Schaefer, V Viard, J Morin, P Ferre, L … - Diabetes, 1994 - Am Diabetes Assoc Expression under the control of the mouse transferrin promoter of a transgene
encoding a soluble secreted derivative of the ectodomain of the human insulin
receptor in transgenic mice results in the accumulation of this ... Cited by 9 - Related articles - BL Direct - All 4 versions
[CITATION] A pilot, multicentre, randomized, double-blind parallel group study evaluating the efficacy …
GC Viberti, RW Bilous, AM El Nahas, A Hersh … - JOURNAL OF NEPHROLOGY, 1992 - WICHTIG EDITORE-MILANO Cited by 3 - Related articles - BL Direct
[CITATION] Lindströ m J, Tuomilehto J, Finnish Diabetes Prevention Study Group: Long-term improvement …
L Wang, N Muromoto, H Hayashi, Y Mitani, H … - Biochemical and Biophysical Research …, 1997 - Elsevier We generated transgenic mice homozygous for the tyrosine kinase-deficient human
insulin receptor (hIR K1030M (+/+)) under control of the insulin receptor
promoter. Similar growth patterns and results of glucose tolerance tests ... Cited by 2 - Related articles - BL Direct - All 5 versions
